Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk

Aruna D. Pradhan, Robert J. Glynn, Jean‐Charles Fruchart, Jean G. MacFadyen, Elaine Zaharris, Brendan M. Everett, Stuart E. Campbell, Ryu Oshima, Pierre Amarenco, Dirk Jacobus Blom, Eliot A. Brinton, Robert H. Eckel, Marshall B. Elam, João Soares Felício, Henry N. Ginsberg, Assen Goudev, Shun Ishibashi, Jacob Joseph, Tatsuhiko Kodama, Wolfgang Köenig, Lawrence A. Leiter, Alberto J. Lorenzatti, Boris Mankovsky, Nikolaus Marx, Børge Grønne Nordestgaard, and 11 more

View at source ↗PDF ↗Article746 citations
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.

Record

Archive ID
doi:10.1056/nejmoa2210645
Published
Nov 5, 2022
Venue
New England Journal of Medicine
DOI
10.1056/nejmoa2210645
PubMed
36342113
Categories
Lipoproteins and Cardiovascular Health
Provenance
openalex

Topics